OXIDATIVE-METABOLISM OF ENCAINIDE - POLYMORPHISM, PHARMACOKINETICS AND CLINICAL CONSIDERATIONS

被引:32
作者
MCALLISTER, CB [1 ]
WOLFENDEN, HT [1 ]
ASLANIAN, WS [1 ]
WOOSLEY, RL [1 ]
WILKINSON, GR [1 ]
机构
[1] VANDERBILT UNIV,DEPT PHARMACOL,NASHVILLE,TN 37232
关键词
D O I
10.3109/00498258609050253
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:483 / 490
页数:8
相关论文
共 23 条
[1]   ENCAINIDE AND ITS METABOLITES - COMPARATIVE EFFECTS IN MAN ON VENTRICULAR ARRHYTHMIA AND ELECTROCARDIOGRAPHIC INTERVALS [J].
CAREY, EL ;
DUFF, HJ ;
RODEN, DM ;
PRIMM, RK ;
WILKINSON, GR ;
WANG, T ;
OATES, JA ;
WOOSLEY, RL .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (02) :539-547
[2]  
DRESEL PE, 1984, J PHARMACOL EXP THER, V228, P180
[3]   INFLUENCE OF THE DEFECTIVE METABOLISM OF SPARTEINE ON ITS PHARMACOKINETICS [J].
EICHELBAUM, M ;
SPANNBRUCKER, N ;
DENGLER, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :189-194
[4]  
ELHARRAR V, 1982, J PHARMACOL EXP THER, V220, P440
[5]  
GOMOLL AW, 1981, PHARMACOLOGIST, V23, P209
[6]   HUMAN-LIVER CYTOCHROMES-P-450 INVOLVED IN POLYMORPHISMS OF DRUG OXIDATION [J].
GUENGERICH, FP ;
DISTLERATH, LM ;
REILLY, PEB ;
WOLFF, T ;
SHIMADA, T ;
UMBENHAUER, DR ;
MARTIN, MV .
XENOBIOTICA, 1986, 16 (05) :367-378
[7]   ENCAINIDE - A NEW AND POTENT ANTI-ARRHYTHMIC AGENT [J].
HARRISON, DC ;
WINKLE, R ;
SAMI, M ;
MASON, J .
AMERICAN HEART JOURNAL, 1980, 100 (06) :1046-1054
[8]   METABOLISM OF [C-14]-DEBRISOQUINE IN MAN [J].
IDLE, JR ;
MAHGOUB, A ;
ANGELO, MM ;
DRING, LG ;
LANCASTER, R ;
SMITH, RL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (03) :257-266
[9]   METABOLITE CUMULATION DURING LONG-TERM ORAL ENCAINIDE ADMINISTRATION [J].
KATES, RE ;
HARRISON, DC ;
WINKLE, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (04) :427-432
[10]   THE EFFECTS OF ENCAINIDE AND ITS MAJOR METABOLITES, O-DEMETHYL ENCAINIDE AND 3-METHOXY-O-DEMETHYL ENCAINIDE, ON EXPERIMENTAL CARDIAC-ARRHYTHMIAS IN DOGS [J].
KERR, MJ ;
ALLEN, JD ;
HARRON, DWG ;
SHANKS, RG .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (03) :449-457